Literature DB >> 21326540

Endovascular treatment of femoral-popliteal disease.

Adam Ryan Geronemus1, Constantino S Peña.   

Abstract

Available and improved options for the treatment of femoral-popliteal disease have increased over the last decade. Even though most patients suffering from claudication due to femoral-popliteal disease are treated with aggressive medical and noninvasive methods, patients with limb-threatening disease and severely lifestyle-limiting symptoms are treated with invasive treatments, which include endovascular treatment options. Unfortunately, the unique forces involved in this vascular segment have challenged the long-term patency and clinical effectiveness of these treatments. The purpose of this brief review is to discuss treatment strategies and options for patients with femoral-popliteal disease. Included in this discussion will be the review of data from recent published studies and late-breaking trials as it pertains to certain treatment strategies.

Entities:  

Keywords:  Superficial femoral artery; angioplasty; claudication; critical limb ischemia; stent

Year:  2009        PMID: 21326540      PMCID: PMC3036472          DOI: 10.1055/s-0029-1242203

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  24 in total

1.  Recanalisation of femoro-popliteal occlusions: improving success rate by subintimal recanalisation.

Authors:  A Bolia; J Brennan; P R Bell
Journal:  Clin Radiol       Date:  1989-05       Impact factor: 2.350

2.  Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.

Authors:  D J Adam; J D Beard; T Cleveland; J Bell; A W Bradbury; J F Forbes; F G R Fowkes; I Gillepsie; C V Ruckley; G Raab; H Storkey
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

3.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

4.  Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.

Authors:  Gunnar Tepe; Thomas Zeller; Thomas Albrecht; Stephan Heller; Uwe Schwarzwälder; Jean-Paul Beregi; Claus D Claussen; Anja Oldenburg; Bruno Scheller; Ulrich Speck
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

5.  Endovascular exclusion of popliteal artery aneurysms with stent-grafts: a prospective single-center experience.

Authors:  Gary M Idelchik; Kathryn G Dougherty; Eduardo Hernandez; Ali Mortazavi; Neil E Strickman; Zvonimir Krajcer
Journal:  J Endovasc Ther       Date:  2009-04       Impact factor: 3.487

6.  Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions.

Authors:  Richard R Saxon; Jeanine M Coffman; Justin M Gooding; Donald J Ponec
Journal:  J Vasc Interv Radiol       Date:  2007-11       Impact factor: 3.464

7.  Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST).

Authors:  Hans Krankenberg; Michael Schlüter; Hermann J Steinkamp; Karlheinz Bürgelin; Dierk Scheinert; Karl-Ludwig Schulte; Erich Minar; Patrick Peeters; Marc Bosiers; Gunnar Tepe; Bernhard Reimers; Felix Mahler; Thilo Tübler; Thomas Zeller
Journal:  Circulation       Date:  2007-06-25       Impact factor: 29.690

8.  ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.

Authors:  Alan T Hirsch; Ziv J Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth A Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2006-03-21       Impact factor: 24.094

9.  Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease.

Authors:  Richard R Saxon; Michael D Dake; Robert L Volgelzang; Barry T Katzen; Gary J Becker
Journal:  J Vasc Interv Radiol       Date:  2008-04-10       Impact factor: 3.464

Review 10.  Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review.

Authors:  Rosemarie Met; Krijn P Van Lienden; Mark J W Koelemay; Shandra Bipat; Dink A Legemate; Jim A Reekers
Journal:  Cardiovasc Intervent Radiol       Date:  2008-04-15       Impact factor: 2.740

View more
  3 in total

Review 1.  Treating femoropopliteal disease: established and emerging technologies.

Authors:  Athanasios Diamantopoulos; Konstantinos Katsanos
Journal:  Semin Intervent Radiol       Date:  2014-12       Impact factor: 1.513

2.  MR imaging of iliofemoral peripheral vascular calcifications using proton density-weighted, in-phase three-dimensional stack-of-stars gradient echo.

Authors:  Marcos P Ferreira Botelho; Ioannis Koktzoglou; Jeremy D Collins; Shivraman Giri; James C Carr; NavYash Gupta; Robert R Edelman
Journal:  Magn Reson Med       Date:  2016-06-14       Impact factor: 4.668

3.  Twelve months follow-up after retrograde recanalization of superficial femoral artery chronic total occlusion.

Authors:  Joanna Wojtasik-Bakalarz; Salech Arif; Michał Chyrchel; Tomasz Rakowski; Krzysztof Bartuś; Dariusz Dudek; Stanisław Bartuś
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-03-10       Impact factor: 1.426

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.